Usage of nanoparticles with their potential toxicity assessment and regulatory guidelines

Toxicology and Environmental Health Sciences

Volumn 5, Issue 2, 2013, Pages 49-54

  Rahman, Md Mujibur ^a   Lee, Jong Kwon ^b   Jeong, Jayoung ^b   Seo, Young Rok ^a  

^a Dongguk University   (South Korea)

^b National Institute of Food and Drug Safety Evaluation   (South Korea)

Author keywords

Applications; Assessment; Guidelines; Nanoparticles; Regulatory; Toxicity

Indexed keywords

CARBON NANOTUBE; COSMETIC; DNA; GOLD NANOPARTICLE; HYDROXYAPATITE; MAGNETIC NANOPARTICLE; NANOPARTICLE; PLATINUM NANOPARTICLE; RNA; SILICON DIOXIDE; SILVER NANOPARTICLE;

ARTICLE; DRUG DELIVERY SYSTEM; DRUG EXPOSURE; FOOD INDUSTRY; GENE TARGETING; HUMAN; NANOMEDICINE; NANOTOXICOLOGY; NEOPLASM; NONHUMAN; ORGANOGENESIS; OXIDATIVE STRESS; PRACTICE GUIDELINE; PRIORITY JOURNAL; REPRODUCTION; RISK ASSESSMENT; SAFETY; TOXICITY TESTING;

EID: 84880987673     PISSN: 20059752     EISSN: 22337784     Source Type: Journal    
DOI: 10.1007/s13530-013-0156-7     Document Type: Article

References (46)

1. Tiede, K. et al. Detection and characterization of engineered nanoparticles in food and the environment. Food Addit. Contam. 25, 795-821, doi: 10. 1080/026 52030802007553 (2008).
2. Asiyanbola, B. & Soboyejo, W. For the surgeon: An introduction to nanotechnology. J. Surg. Educ. 65, 155-161 (2008).
3. Science Policy Council (U. S.). Nanotechnology Workgroup. & United States. Environmental Protection Agency. U. S. Environmental Protection Agency nanotechnology white paper (Science Policy Council, U. S. Environmental Protection Agency, 2007).
4. Grieneisen, M. L. & Zhang, M. Nanoscience and nanotechnology: evolving definitions and growing footprint on the scientific landscape. Small7, 2836-2839, doi: 10. 1002/smll. 201100387 (2011).
5. Dwyer, J. M. Applied Statistical Decision-Theory - Raiffa, H, Schlaifer, R. Behav. Sci. 7, 103-104 (1962).
6. Maynard, A. D. Don't define nanomaterials. Nature475, 31, doi: 10. 1038/475031a (2011).
7. Zhang, L. et al. Nanoparticles in medicine: therapeutic applications and developments. Clinical. Pharmacology and Therapeutics83, 761-769, doi: 10. 1038/sj. clpt. 6100400 (2008).
8. Goldberg, M., Langer, R. & Jia, X. Q. Nanostructured materials for applications in drug delivery and tissue engineering. J. Biomat. Sci-Polym. E18, 241-268 (2007).
9. Carino, I. S. et al. Silica-based mesoporous materials as drug delivery system for methotrexate release. Drug Delivery14, 491-495, doi: 10. 1080/10717540701606 244 (2007).
10. Vallet-Regi, M., Balas, F. & Arcos, D. Mesoporous materials for drug delivery. Angew. Chem. Int. Ed. Engl. 46, 7548-7558, doi: 10. 1002/anie. 200604488 (2007).
11. Vallet-Regi, M. Ordered mesoporous materials in the context of drug delivery systems and bone tissue engineering. Chemistry12, 5934-5943, doi: 10. 1002/chem. 200600226 (2006).
12. Popovtzer, R. et al. Targeted gold nanoparticles enable molecular CT imaging of cancer. Nano. Lett. 8, 4593-4596 (2008).
13. Popovtzer, R. et al. Electrochemical lab on a chip for high-throughput analysis of anticancer drugs efficiency. Nanomedicine: Nanotechnology, Biology, and Medicine4, 121-126, doi: 10. 1016/j. nano. 2008. 03. 002 (2008).
14. Huff, T. B. et al. Hyperthermic effects of gold nanorods on tumor cells. Nanomedicine (Lond)2, 125-132, doi: 10. 2217/17435889. 2. 1. 125 (2007).
15. Yu, Y. et al. Synthesis and anticancer activity of lipophilic platinum (II) complexes of 3, 5-diisopropylsalicylate. European Journal of Medicinal Chemistry43, 1438-1443, doi: 10. 1016/j. ejmech. 2007. 09. 006 (2008).
16. Park, J. H. et al. Biodegradable luminescent porous silicon nanoparticles for in vivo applications. Nat. Mater8, 331-336, doi: 10. 1038/nmat2398 (2009).
17. Kim, K., Lee, H. S. & Kim, N. H. Silver-particle-based surface-enhanced resonance Raman scattering spectroscopy for biomolecular sensing and recognition. Analytical and Bioanalytical Chemistry388, 81-88, doi: 10. 1007/s00216-007-1182-6 (2007).
18. Faraji, A. H. & Wipf, P. Nanoparticles in cellular drug delivery. Bioorganic & Medicinal Chemistry17, 2950-2962, doi: 10. 1016/j. bmc. 2009. 02. 043 (2009).
19. Sajja, H. K. et al. Development of multifunctional nanoparticles for targeted drug delivery and noninvasive imaging of therapeutic effect. Current Drug Discovery Technologies6, 43-51 (2009).
20. Dvir, T. et al. Nanowired three-dimensional cardiac patches. Nature Nanotechnology6, 720-725 (2011).
21. Hannig, M. & Hannig, C. Nanomaterials in preventive dentistry. Nature Nanotechnology5, 565-569 (2010).
22. Li, L. et al. Repair of enamel by using hydroxyapatite nanoparticles as the building blocks. J. Mater Chem. 18, 4079-4084 (2008).
23. Shubayev, V. I., Pisanic, T. R., 2nd & Jin, S. Magnetic nanoparticles for theragnostics. Advanced Drug Delivery Reviews61, 467-477, doi: 10. 1016/j. addr. 2009. 03. 007 (2009).
24. Jin, S., Leach, J. C. & Ye, K. Nanoparticle-mediated gene delivery. Methods Mol. Biol. 544, 547-557, doi: 10. 1007/978-1-59745-483-4_34 (2009).
25. Dobson, J. Gene therapy progress and prospects: magnetic nanoparticle-based gene delivery. Gene Therapy13, 283-287, doi: 10. 1038/sj. gt. 3302720 (2006).
26. Harris, T. J. et al. Tissue-specific gene delivery via nanoparticle coating. Biomaterials31, 998-1006, doi: 10. 1016/j. biomaterials. 2009. 10. 012 (2010).
27. Card, J. W., Jonaitis, T. S., Tafazoli, S. & Magnuson, B. A. An appraisal of the published literature on the safety and toxicity of food-related nanomaterials. Critical Reviews in Toxicology41, 22-49, doi: 10. 3109/1040 8444. 2010. 524636 (2011).
28. Rohner, F. et al. Synthesis, characterization, and bioavailability in rats of ferric phosphate nanoparticles. The Journal of Nutrition137, 614-619 (2007).
29. Kuan, C. Y., Yee-Fung, W., Yuen, K. H. & Liong, M. T. Nanotech: propensity in foods and bioactives. Critical Reviews in Food Science and Nutrition52, 55-71, doi: 10. 1080/10408398. 2010. 494259 (2012).
30. Hood, E. Nanotechnology: Looking as we leap. Environmental Health Perspectives112, A740-A749 (2004).
31. Borm, P. J. et al. The potential risks of nanomaterials: a review carried out for ECETOC. Particle and Fibre Toxicology3, 11, doi: 10. 1186/1743-8977-3-11 (2006).
32. Choi, J. E. et al. A safety assessment of phototoxicity and sensitization of SiO(2) nanoparticles. Mol. Cell Toxicol. 7, 171-176, doi: DOI 10. 1007/s13273-011-0023-z (2011).
33. Stone, V., Johnston, H. & Clift, M. J. Air pollution, ultrafine and nanoparticle toxicology: cellular and molecular interactions. IEEE Transactions on Nanobioscience6, 331-340 (2007).
34. AshaRani, P. V., Low Kah Mun, G., Hande, M. P. & Valiyaveettil, S. Cytotoxicity and genotoxicity of silver nanoparticles in human cells. Acs Nano3, 279-290, doi: 10. 1021/nn800596w (2009).
35. Nel, A. E. et al. Understanding biophysicochemical interactions at the nano-bio interface. Nat. Mater8, 543-557, doi: 10. 1038/NMAT2442 (2009).
36. Oberdorster, G. Safety assessment for nanotechnology and nanomedicine: concepts of nanotoxicology. Journal of Internal Medicine267, 89-105, doi: 10. 1111/ j. 1365-2796. 2009. 02187. x (2010).
37. Magnuson, B. A., Card, J. W., Jonaitis, T. S. & Tafazoli, S. An appraisal of the published literature on the safety and toxicity of food-related nanomaterials. Crit. Rev. Toxicol. 41, 20-49, doi: Doi 10. 3109/10408444. 2010. 524636 (2011).
38. Oberdorster, G. Lung particle overload: implications for occupational exposures to particles. Regulatory Toxicology and Pharmacology: RTP21, 123-135, doi: 10. 1006/rtph. 1995. 1017 (1995).
39. Bermudez, E. et al. Pulmonary responses of mice, rats, and hamsters to subchronic inhalation of ultrafine titanium dioxide particles. Toxicol. Sci. 77, 347-357, doi: 10. 1093/toxsci/kfh019 (2004).
40. Hext, P. M., Tomenson, J. A. & Thompson, P. Titanium dioxide: inhalation toxicology and epidemiology. The Annals of Occupational Hygiene49, 461-472, doi: 10. 1093/annhyg/mei012 (2005).
41. Driscoll, K. E., Carter, J. M. & Borm, P. J. Antioxidant defense mechanisms and the toxicity of fibrous and nonfibrous particles. Inhalation Toxicology14, 101-118, doi: 10. 1080/089583701753338668 (2002).
42. Nel, A., Xia, T., Madler, L. & Li, N. Toxic potential of materials at the nanolevel. Science311, 622-627, doi: DOI 10. 1126/science. 1114397 (2006).
43. Drezek, R. A. & Tour, J. M. Is nanotechnology too broad to practise? Nat. Nanotechnol. 5, 168-169, doi: 10. 1038/nnano. 2010. 37 (2010).
44. Becker, H., Herzberg, F., Schulte, A. & Kolossa-Gehring, M. The carcinogenic potential of nanomaterials, their release from products and options for regulating them. Int. J. Hyg. Environ. Health3, 231-238 (2011).
45. Organisation for Economic Cooperation and Development (OECD). Current developments/activities on the safety of manufactured nanomaterials (2011).
46. EPA. TSCA Inventory Status of Nanoscale Substances-General Approach (2008).